Purinergic signaling in the hallmarks of cancer
AR Campos-Contreras, M Díaz-Muñoz… - Cells, 2020 - mdpi.com
Cancer is a complex expression of an altered state of cellular differentiation associated with
severe clinical repercussions. The effort to characterize this pathological entity to understand …
severe clinical repercussions. The effort to characterize this pathological entity to understand …
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
L Qin, J Wu - Environmental Research, 2023 - Elsevier
Oral cavity carcinomas are the most frequent malignancies among head and neck
malignancies. Oral tumors include not only oral cancer cells with different potency and …
malignancies. Oral tumors include not only oral cancer cells with different potency and …
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial–mesenchymal transition, cell migration, and invasion
CL Alvarez, MF Troncoso… - Journal of Cellular …, 2022 - Wiley Online Library
Under nonpathological conditions, the extracellular nucleotide concentration remains
constant and low (nM range) because of a close balance between ATP release and ATP …
constant and low (nM range) because of a close balance between ATP release and ATP …
Purinergic signaling: Diverse effects and therapeutic potential in cancer
J Kaur, S Dora - Frontiers in Oncology, 2023 - frontiersin.org
Regardless of improved biological insights and therapeutic advances, cancer is consuming
multiple lives worldwide. Cancer is a complex disease with diverse cellular, metabolic, and …
multiple lives worldwide. Cancer is a complex disease with diverse cellular, metabolic, and …
[HTML][HTML] PSB 603–a known selective adenosine A2B receptor antagonist–has anti-inflammatory activity in mice
M Kotańska, M Szafarz, K Mika, A Dziubina… - Biomedicine & …, 2021 - Elsevier
A 2B adenosine receptors are present in a wide spectrum of tissues, especially on cells of
the immune system. Since these particular receptors have the lowest, of all adenosine …
the immune system. Since these particular receptors have the lowest, of all adenosine …
Lidocaine induces apoptosis in head and neck squamous cell carcinoma through activation of bitter taste receptor T2R14
ZA Miller, A Mueller, TB Kim, JF Jolivert, RZ Ma… - Cell reports, 2023 - cell.com
Head and neck squamous cell carcinomas (HNSCCs) have high mortality and significant
treatment-related morbidity. It is vital to discover effective, minimally invasive therapies that …
treatment-related morbidity. It is vital to discover effective, minimally invasive therapies that …
The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense desmoplastic
stroma that impedes drug delivery, reduces parenchymal blood flow, and suppresses the …
stroma that impedes drug delivery, reduces parenchymal blood flow, and suppresses the …
Adenosine receptor A2B negatively regulates cell migration in ovarian carcinoma cells
AR Campos-Contreras, A González-Gallardo… - International Journal of …, 2022 - mdpi.com
The purinergic system is fundamental in the tumor microenvironment, since it regulates
tumor cell interactions with the immune system, as well as growth and differentiation in …
tumor cell interactions with the immune system, as well as growth and differentiation in …
BTK isoforms p80 and p65 are expressed in head and neck squamous cell carcinoma (HNSCC) and involved in tumor progression
AC Betzler, H Strobel, T Abou Kors, J Ezić, K Lesakova… - Cancers, 2023 - mdpi.com
Simple Summary Bruton's Tyrosine Kinase (BTK) was originally considered to be primarily
expressed in cells of hematopoietic origin. Apart from the 77 kDa BTK isoform expressed in …
expressed in cells of hematopoietic origin. Apart from the 77 kDa BTK isoform expressed in …
Current adenosinergic therapies: what do cancer cells stand to gain and lose?
A key objective in immuno-oncology is to reactivate the dormant immune system and
increase tumour immunogenicity. Adenosine is an omnipresent purine that is formed in …
increase tumour immunogenicity. Adenosine is an omnipresent purine that is formed in …